أرسل هذا في رسالة قصيرة: Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer

 ______     _____              _    _    ______   
|      \\  |  ___||   ____    | || | || |      \\ 
|  --  //  | ||__    |    \\  | || | || |  --  // 
|  --  \\  | ||__    | [] ||  | \\_/ || |  --  \\ 
|______//  |_____||  |  __//   \____//  |______// 
`------`   `-----`   |_|`-`     `---`   `------`  
                     `-`